Pfizer Inc (PFE) fundamentals from SEC filings — revenue $62.6B, net margin 12.4%, diluted EPS $1.36 in FY2025. Revenue, margins, EPS and free cash flow, year by year.
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $73.6B | $91.8B | $50.9B | $63.6B | $62.6B |
| Net income | $22.0B | $31.4B | $2.1B | $8.0B | $7.8B |
| Net margin | 29.9% | 34.2% | 4.2% | 12.6% | 12.4% |
| Diluted EPS | $3.85 | $5.47 | $0.37 | $1.41 | $1.36 |
| Free cash flow | $29.9B | $26.0B | $4.8B | $9.8B | $9.1B |
Figures are as reported to the SEC (EDGAR companyfacts), in the filer's own fiscal years.
Sign in to PortfolioX for the full analysis — ten years of history, segment and geographic breakdowns, valuation multiples, analyst estimates and filings. · PortfolioX home